Journals / Turkish Journal of Pediatrics / 2018 / Cilt: 60 - Sayı: 2

Corticosteroid phobia among parents of asthmatic children

Pages
142–146
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Anychange in asthma treatment regimen due to corticophobia was found to berelated with poor asthma control level (p: 0.004).The impact of parental information about the effects and importance of steroidsgiven by the physicians on better asthma control was found to be highlysignificant (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Asthma is one of the most prevalent chronic diseases among children.Its prevalence and morbidity have been rising in recent decades.
📊
Key Findings & Data:Pediatricasthma causes a significant burden on families; allergen-avoidance measures,uncontrolled disease, and disease severity which are the major cost predictorsof childhood asthma in Turkey.
💡
Conclusion & Impact:Anychange in asthma treatment regimen due to corticophobia was found to berelated with poor asthma control level (p: 0.004).The impact of parental information about the effects and importance of steroidsgiven by the physicians on better asthma control was found to be highlysignificant (p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Asthma is one of the most prevalent chronic diseases among children.Its prevalence and morbidity have been rising in recent decades. Pediatricasthma causes a significant burden on families; allergen-avoidance measures,uncontrolled disease, and disease severity which are the major cost predictorsof childhood asthma in Turkey. Inhaled corticosteroids (ICS) are consideredas cornerstone medications in asthma management which reduce asthmamorbidity and mortality. Our aim was to address corticosteroid phobia incaregivers of asthmatic children and its impact on asthma management.Five hundred caregivers of asthmatic children were interviewed using structuredquestionnaire in this study.Over fifty percent of the caregivers (56.8%), most of whom (82.6%) are alreadyaware of using corticosteroids in their anti-asthma drug regimen, mentionedthat they are afraid of using them. Almost one fourth of caregivers (24.8%)made either some changes in their treatment regimen or stopped using thedrugs due to corticophobia. Of the caregivers 55.2% had no idea about theside effects of corticosteroids and only 12.6% of them mentioned that theywere informed by their physicians about the effects of corticosteroids. Anychange in asthma treatment regimen due to corticophobia was found to berelated with poor asthma control level (p: 0.004).The impact of parental information about the effects and importance of steroidsgiven by the physicians on better asthma control was found to be highlysignificant (p

🔖

Cite This Article

Güler, N., Tamay, Z., Özçeker, D., Uçkun, U., İslamova, D. (2022). Corticosteroid phobia among parents of asthmatic children. Turkish Journal of Pediatrics, Cilt: 60 - Sayı: 2, 142–146. https://ajindex.com/articles/613154

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Global Initiative for Asthma (GINA) Program 2016. www.ginaasthma.org 2. Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull WHO 2005
  2. Akcay A, Tamay Z, HocaogluAB, Ergin A, Guler N. Risk factors affecting asthma prevalence in adolescents living in Istanbul, Turkey. AllergolImmunopathol (Madr) 2014
  3. Ones U, Akcay A, Tamay Z, Guler N, Zencir M. Rising trend of asthma prevalence among Turkish school children (ISAAC phases I and III). Allergy 2006
  4. O’Byrne PM, Pedersen S, Schatz M, et al. The poorly explored impact of uncontrolled asthma. Chest 2013
  5. Bateman ED, Reddel HK, Eriksson G, et al. Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol 2010
  6. Beyhun NE, Soyer OU, Kuyucu S, et al. A multi-center survey of childhood asthma in Turkey-I: The cost and its determinants. Pediatr Allergy Immunol 2009
  7. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001
  8. Rand CS. Non-adherence with asthma therapy: more than just forgetting. J Pediatr 2005
  9. Brook U, Mendelberg A, Heim M. Increasing parental knowledge of asthma decreases the hospitalization of the child: A pilot study. J Asthma 1993
  10. Cetinkaya F. Reasons for discontinuation of antiasthma drugs in children with asthma coming from lower socioeconomic classes in a developing country. Allergy Asthma Proc 2007
  11. Rizzo MC, Solé D. Inhaled corticosteroids in the treatment of respiratory allergy: Safety vs. efficacy. J Pediatr (Rio J) 2006
  12. 82(5 Suppl): S198-S205. 13. Skoner JD, Schaffner TJ, Schad CA, Kwon AY, Skoner DP. Addressing steroid phobia: improving the riskbenefit ratio with new agents. Allergy Asthma Proc 2008
  13. Egan JJ, Maden C, Kaira S, Adams JE, Eastell R, Woodcock AA. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J 1999
  14. Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or noncorticotsteroid treatment for twoyears. Thorax 2001
  15. Becker AB, Kuznetsova O, Vermeulen J, et al
  16. Pediatric Montelukast Linear Growth Study Group. Lineargrowth in prepubertal asthmatic chi